Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
28.00
+0.01
(+0.04%)
After-Hours: 20:00
Ambrx Biopharma Cash and Short Term Investments (Quarterly): 225.26M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 225.26M |
| June 30, 2023 | 235.09M |
| March 31, 2023 | 157.52M |
| December 31, 2022 | 84.48M |
| June 30, 2022 | 110.89M |
| Date | Value |
|---|---|
| December 31, 2021 | 170.06M |
| June 30, 2021 | 167.20M |
| June 30, 2021 | 167.20M |
| December 31, 2020 | 90.46M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
84.48M
Minimum
Dec 2022
235.09M
Maximum
Jun 2023
156.46M
Average
167.20M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Johnson & Johnson | 26.22B |
| Axonics Inc | 332.81M |
| Harpoon Therapeutics Inc (DELISTED) | 31.61M |
| Merck & Co Inc | 5.619B |
| RayzeBio inc (DELISTED) | 540.17M |